Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

Share Price is delayed by 15 minutes
Get Live Data
533.00    8.00 (1.52%)
Bid:
530.00
Ask:
535.00
Spread: 5.00 (0.943%)
Market Cap: £306.70m
MAB1 Live PriceLast checked at - London Stock Exchange

Intraday Mortgage Advice Bureau Share Chart

Trading Update

22 Jan 2019 07:00

RNS Number : 6986N
Mortgage Advice Bureau(Holdings)PLC
22 January 2019
 

22 January 2019

Mortgage Advice Bureau (Holdings) plc ("MAB" or the "Group")

Trading Update 

Mortgage Advice Bureau (Holdings) plc (AIM:MAB1), one of the UK's leading consumer intermediary brands and specialist Appointed Representative Networks, today issues a trading update for the year ended 31 December 2018, ahead of publishing its final results announcement on Tuesday, 19 March 2019(1).

Revenue for the year ended 31 December 2018 increased by 13% to £123m driven by a 12% increase in the average number of Advisers to 1,130 in the year ended 31 December 2018 (2017: 1,008). The total number of Advisers had increased to 1,213 at 31 December 2018, an increase of 135 or 13% since last year end (2017: 1,078). For 2018 as a whole, we saw an increase in average revenue per adviser of 1%, continuing our growth in productivity despite the ongoing economic uncertainty driven by the Brexit agenda and a reduction in housing transactions overall.

The Group's profit before tax for the year ended 31 December 2018 is broadly in line with the Board's expectations. At 31 December 2018, the Group had a strong balance sheet with a cash position of over £25m, including over £13m of unrestricted cash balances. 

Although UK Finance has not recently updated its estimates for gross new mortgage lending for 2018 and 2019, the current information and run rates broadly support their previous estimates of £260bn and £271bn for 2018 and 2019 respectively, indicating that the market is likely to be relatively flat in the near term. These figures exclude Product Transfers, and it has only been over the last year or so that the large lenders have engaged intermediaries to help them to retain their existing mortgage borrowers through product transfers, with intermediaries continuing to grow their share of this market. UK Finance has recently revised its original estimates for the size of the product transfer market, indicating an annual market size of c. £140bn.

(1) It is expected that a proposed final dividend in respect of the year ended 31 December 2018 will be paid on 24 May 2019 to shareholders on the register at close of business on 26 April 2019.

Peter Brodnicki, CEO of Mortgage Advice Bureau (Holdings) plc, said:

"MAB has delivered another strong performance despite the uncertainty caused by the ongoing Brexit negotiations. We continue to grow our market share and invest in accordance with our very clear strategy to ensure continued and sustainable growth.

 "We are looking forward to capitalising upon our recent protection initiatives to increase performance whilst also delivering the initial phase of our next generation MIDAS technology in the first half of this year. Both of these initiatives are already proving to be important recruitment drivers for Appointed Representatives, advisers and lead sources. This initial phase and further releases across 2019 and 2020 will benefit MAB advisers and customers, through improvements in efficiency, productivity, lead generation, product offering and customer experience. We are excited about how delivering this will help us to attract more advisers and customers into MAB, assisting our future growth plans."

 

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Enquiries:

Mortgage Advice Bureau (Holdings) plc +44 (0)1332 525007

Peter Brodnicki, Chief Executive Officer

Ben Thompson, Managing Director

David Preece, Chief Operating Officer

Lucy Tilley, Finance Director

Nominated Adviser and Broker: +44 (0)20 7260 1000

Numis Securities Limited

Stephen Westgate / Jamie Lillywhite (Corporate Finance)

Michael Burke (Corporate Broking)

 

Media Enquiries:

 

investorrelations@mab.org.uk

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSEEESFFUSELF
Date   Source Headline
29th Sep 20173:36 pmRNSDirector/PDMR Shareholding
26th Sep 20177:00 amRNSInterim Results
20th Sep 201710:39 amRNSHolding(s) in Company
15th Sep 20177:00 amRNSDirector/PDMR Shareholding
31st Aug 201712:46 pmRNSDirector/PDMR Shareholding
14th Aug 20174:18 pmRNSDirectors' Shareholdings and PDMR notification
11th Aug 20177:00 amRNSHolding(s) in Company
31st Jul 20175:26 pmRNSDirector/PDMR Shareholding
25th Jul 20177:00 amRNSPre-close Trading Update
14th Jul 20174:19 pmRNSDirector/PDMR Shareholding
7th Jul 20173:21 pmRNSHolding(s) in Company
30th Jun 20176:21 pmRNSDirector/PDMR Shareholding
14th Jun 20173:51 pmRNSDirector/PDMR Shareholding
1st Jun 20173:42 pmRNSDirectors' Shareholdings and PDMR notification
24th May 20172:43 pmRNSResult of AGM
24th May 20177:00 amRNSAGM Statement
15th May 20175:56 pmRNSDirector/PDMR Shareholding
10th May 20174:23 pmRNSDirector/PDMR Shareholding
28th Apr 201712:21 pmRNSDirector/PDMR Shareholding
19th Apr 20174:53 pmRNSHolding(s) in Company
19th Apr 20174:52 pmRNSGrant of Options
18th Apr 20176:15 pmRNSDirector/PDMR Shareholding
12th Apr 20176:28 pmRNSExercise of Options and Sale of Ordinary Shares
11th Apr 20171:55 pmRNSPosting of Accounts and Notice of AGM
6th Apr 20176:20 pmRNSBlock Admission Application
31st Mar 20176:00 pmRNSDirector/PDMR Shareholding
28th Mar 20176:30 pmRNSHolding(s) in Company
28th Mar 20177:00 amRNSFinal Results
14th Mar 20174:27 pmRNSDirector/PDMR Shareholding
3rd Mar 20175:47 pmRNSDirector/PDMR Shareholding
28th Feb 20174:58 pmRNSDirector/PDMR Shareholding
14th Feb 20173:14 pmRNSDirector/PDMR Shareholding
31st Jan 20174:27 pmRNSDirector/PDMR Shareholding
27th Jan 20177:00 amRNSTrading Statement
16th Jan 20173:56 pmRNSDirector/PDMR Shareholding
23rd Dec 201612:42 pmRNSDirector/PDMR Shareholding
14th Dec 20166:26 pmRNSDirector/PDMR Shareholding
14th Dec 20164:44 pmRNSHolding(s) in Company
9th Dec 20167:00 amRNSAustralilan Joint Venture
30th Nov 20164:08 pmRNSDirector/PDMR Shareholding
29th Nov 20165:09 pmRNSHolding(s) in Company
28th Nov 20166:18 pmRNSHolding(s) in Company
18th Nov 20168:42 amRNSHolding(s) in Company
14th Nov 20165:00 pmRNSDirector/PDMR Shareholding
3rd Nov 20165:07 pmRNSDirector/PDMR Shareholding
31st Oct 201612:59 pmRNSDirectors' Shareholdings and PDMR Notification
14th Oct 20165:31 pmRNSDirector/PDMR Shareholding
4th Oct 20165:34 pmRNSHolding(s) in Company
3rd Oct 20163:34 pmRNSHolding(s) in Company
3rd Oct 20167:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.